FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108476002: Torasemide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173010019 Torsemide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3664878010 Torasemide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3664879019 Torasemide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
54981000195110 torasemide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
855611000241112 torasémide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70111000195114 Torasemid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Torasemide (substance) Is a Medicinal product acting as saluretic (product) false Inferred relationship Some
Torasemide (substance) Is a Loop diuretic false Inferred relationship Some
Torasemide (substance) Is a Saluretic agent (substance) true Inferred relationship Some
Torasemide (substance) Is a Loop diuretic (substance) true Inferred relationship Some
Torasemide (substance) Is a Aminopyridine true Inferred relationship Some
Torasemide (substance) Is a Sulfonylurea (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Torasemide 20 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Product containing precisely torasemide 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Torsemide 20mg/2mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Torsemide 50mg/5mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Torsemide 10mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Product containing torasemide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Torasemide 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Torasemide 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Torasemide 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Product containing torasemide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Torasemide-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Torsemide 10mg/mL injection solution 5mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Torsemide 20mg/2mL injection solution 2mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some
Torasemide adverse reaction Causative agent (attribute) True Torasemide (substance) Inferred relationship Some 1
Allergy to torasemide Causative agent (attribute) False Torasemide (substance) Inferred relationship Some
Allergy to torasemide Causative agent (attribute) True Torasemide (substance) Inferred relationship Some 1
Torasemide 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some 1
Torasemide 2.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Torasemide (substance) Inferred relationship Some 1
Torasemide 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some 1
Torasemide 5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Torasemide (substance) Inferred relationship Some 1
Torasemide 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some 1
Torasemide 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Torasemide (substance) Inferred relationship Some 1
Torasemide 20 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some 1
Torasemide 20 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Torasemide (substance) Inferred relationship Some 1
Product containing precisely torasemide 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Torasemide (substance) Inferred relationship Some 1
Product containing precisely torasemide 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Torasemide (substance) Inferred relationship Some 1
Torasemide 2.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Torasemide (substance) Inferred relationship Some 1
Torasemide 5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Torasemide (substance) Inferred relationship Some 1
Torasemide 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Torasemide (substance) Inferred relationship Some 1
Torasemide 20 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Torasemide (substance) Inferred relationship Some 1
Product containing precisely torasemide 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Torasemide (substance) Inferred relationship Some 1
Torasemide only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Product containing only torasemide in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Product containing only torasemide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Spironolactone 50 mg and torasemide 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Torasemide (substance) Inferred relationship Some 1
Spironolactone 50 mg and torasemide 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Torasemide (substance) Inferred relationship Some 1
Product containing spironolactone and torasemide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Product containing only spironolactone and torasemide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Product containing spironolactone and torasemide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Product containing only spironolactone and torasemide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Torasemide (substance) Inferred relationship Some 1
Spironolactone 50 mg and torasemide 20 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Torasemide (substance) Inferred relationship Some 1
Spironolactone 50 mg and torasemide 20 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Torasemide (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start